WVE Wave Life Sciences Ltd. - Ordinary Shares
Informazioni su Wave Life Sciences Ltd. - Ordinary Shares Panoramica della società da Wikipedia
WVE Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
WVE Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
WVE Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
- Acquisto forte 6 30,0%
- Compra 13 65,0%
- Mantieni 1 5,0%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
16 analisti · 2026-08-17Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-0.34 | $-0.31 | -0.03% |
| 31 Marzo 2026 | $-0.13 | $-0.33 | 0.20% |
| 31 Dicembre 2025 | $-0.30 | $-0.27 | -0.03% |
| 30 Settembre 2025 | $-0.32 | $-0.30 | -0.02% |
| 30 Giugno 2025 | $-0.31 | $-0.29 | -0.02% |
| 31 Marzo 2025 | $-0.29 | $-0.26 | -0.03% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 13
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $43M | $108M | $113M | $4M | $41M | $20M | $16M | $14M | $4M | $1M | $152.0K | |
| R&D Expense | $183M | $160M | $130M | $116M | $122M | $131M | $175M | $134M | $79M | $41M | $9M | |
| SG&A Expense | $75M | $59M | $51M | $51M | $46M | $43M | $49M | $40M | $27M | $16M | $10M | |
| Operating Expenses | $258M | $219M | $181M | $166M | $168M | $173M | $224M | $174M | $106M | $57M | $19M | |
| Operating Income | $-215M | $-110M | $-68M | $-163M | $-127M | $-153M | $-208M | $-160M | $-102M | $-56M | $-19M | |
| Other Non-op | $527.0K | $3M | $2M | $7.0K | $5M | $2M | $10M | $10M | $-331.0K | $-50.0K | $56.0K | |
| Pretax Income | $-204M | $-97M | $-58M | $-161M | $-122M | $-151M | $-194M | $-147M | $-101M | $-55M | $-19M | |
| Income Tax | $0 | $0 | $-677.0K | $681.0K | $-204.0K | $-841.0K | $0 | $69.0K | $842.0K | $482.0K | $44.0K | |
| Net Income | $-204M | $-97M | $-58M | $-162M | $-122M | $-150M | $-194M | $-147M | $-102M | $-56M | $-19M | |
| EPS (Basic) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | · | · | · | · | · | · | |
| Shares (Basic) | 168,649,795 | 138,277,468 | 106,097,268 | 78,855,810 | 51,825,566 | · | · | · | · | · | · | |
| Shares (Diluted) | 168,649,795 | 138,277,468 | 106,097,268 | 78,855,810 | 51,825,566 | · | · | · | · | · | · |
Stato Patrimoniale 23
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $602M | $302M | $200M | $88M | $151M | $184M | $147M | $175M | $143M | $150M | $161M | |
| Receivables | $1M | $1M | $21M | · | · | $30M | $20M | $10M | $1M | · | · | |
| Prepaid Expense | $8M | $10M | $10M | $8M | $7M | $10M | $10M | $7M | $7M | $1M | $146.0K | |
| Other Current Assets | $3M | $7M | $4M | $2M | $5M | $5M | $9M | $11M | · | · | · | |
| Current Assets | $615M | $320M | $235M | $99M | $163M | $230M | $185M | $202M | $150M | $152M | $161M | |
| PP&E (Net) | $7M | $10M | $13M | $17M | $22M | $29M | $36M | $40M | $27M | $9M | $3M | |
| PP&E (Gross) | $57M | $56M | $56M | $55M | $54M | $54M | $53M | $49M | $32M | $11M | $4M | |
| Accum. Depreciation | $50M | $46M | $43M | $38M | $32M | $25M | $17M | $10M | $4M | $2M | $2M | |
| Other Non-current Assets | $16.0K | $55.0K | $156.0K | · | · | · | · | · | · | · | · | |
| Total Assets | $638M | $352M | $275M | $146M | $207M | $279M | $284M | $296M | $182M | $165M | $165M | |
| Accounts Payable | $16M | $16M | $13M | $17M | $7M | $14M | $9M | $13M | $8M | $5M | $3M | |
| Accrued Liabilities | $7M | $5M | $2M | $4M | $4M | $2M | $5M | $6M | $3M | · | · | |
| Current Liabilities | $95M | $111M | $186M | $72M | $64M | $121M | $118M | $130M | $18M | $12M | $4M | |
| Capital Leases | $9M | $18M | $25M | $32M | $25M | $26M | $29M | · | · | $16.0K | $78.0K | |
| Other Non-current Liabilities | · | · | · | $190.0K | · | $474.0K | $2M | $2M | $2M | $796.0K | $163.0K | |
| Total Liabilities | $112M | $135M | $227M | $184M | $167M | $189M | $213M | $215M | $34M | $22M | $4M | |
| Common Stock | $1.62B | $1.18B | $935M | $803M | $750M | $694M | $540M | $375M | $310M | $216M | $185M | |
| Paid-in Capital | $228M | $156M | $129M | $119M | $88M | $72M | $57M | $38M | $22M | $10M | $3M | |
| Retained Earnings | $-1.33B | $-1.12B | $-1.02B | $-967M | $-806M | $-683M | $-533M | $-340M | $-193M | $-90M | $-35M | |
| AOCI | $-250.0K | $-262.0K | $-124.0K | $-29.0K | $181.0K | $389.0K | $267.0K | $153.0K | $116.0K | $-291.0K | $41.0K | |
| Stockholders' Equity | $518M | $210M | $40M | $-45M | $32M | $83M | $64M | $73M | $140M | $135M | $153M | |
| Liabilities + Equity | $638M | $352M | $275M | $146M | $207M | $279M | $284M | $296M | $182M | $165M | $165M | |
| Shares Outstanding | 187,660,263 | 153,037,286 | 119,162,234 | 86,924,643 | 59,841,116 | 48,778,678 | 34,340,690 | 29,472,197 | 27,829,079 | 23,502,169 | 21,551,423 |
Flusso di cassa 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | $2M | $784.0K | $594.0K | |
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | $4M | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | · | $908.0K | $-698.0K | $36.0K | |
| Operating Cash Flow | $-187M | $-151M | $-19M | $-128M | $-89M | $-116M | $-188M | $-23M | $-84M | $-32M | $-13M | |
| CapEx | $718.0K | $938.0K | $1M | $1M | $560.0K | $1M | $4M | $10M | $19M | $6M | $2M | |
| Investing Cash Flow | $-718.0K | $-938.0K | $-1M | $-1M | $-560.0K | $-1M | $-4M | $-10M | $-19M | $-6M | · | |
| Stock Issued | · | · | $94M | $51M | · | $94M | $162M | $60M | $94M | $30M | $12M | |
| Financing Cash Flow | $488M | $254M | $133M | $67M | $56M | $155M | $164M | $65M | $94M | $29M | · | |
| Net Change in Cash | $300M | $102M | $112M | $-62M | $-34M | $37M | $-28M | $32M | $-8M | $-8M | $160M | |
| Taxes Paid | · | · | · | · | · | · | · | · | $-11.0K | $554.0K | · |
Tassi di Crescita 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -60.6% | -4.4% | 3005.1% | -91.1% | 104.0% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 127.1% | 38.3% | 78.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 16.3% | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $43M | $108M | $113M | $4M | $41M | $20M | $16M | $14M | $4M | $1M | $152.0K | |
| Net Income TTM | $-204M | $-97M | $-58M | $-162M | $-122M | $-150M | $-194M | $-147M | $-102M | $-56M | $-19M | |
| P/E | -14.0 | -17.7 | -9.4 | -3.4 | -1.3 | · | · | · | · | · | · | |
| P / Tangible Book | 6.2 | 9.0 | 15.2 | · | 5.8 | 4.6 | · | · | · | · | · | |
| Earnings Yield | -7.1% | -5.7% | -10.7% | -29.3% | -75.2% | · | · | · | · | · | · |
Conto Economico 15
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $38M | · | · | $9M | $9M | · | · | $20M | $13M | $49M | $22M | $13M | $285.0K | $375.0K | $2M | |
| R&D Expense | $51M | $47M | $53M | $46M | $43M | $41M | $45M | $41M | $40M | $33M | $32M | $33M | $31M | $28M | $30M | $27M | |
| SG&A Expense | $25M | $22M | $21M | $18M | $18M | $18M | $16M | $15M | $14M | $14M | $13M | $12M | $12M | $12M | $13M | $12M | |
| Operating Expenses | $76M | $70M | $74M | $64M | $61M | $59M | $61M | $56M | $55M | $47M | $45M | $46M | $43M | $39M | $43M | $40M | |
| Operating Income | $-74M | $-31M | $-56M | $-56M | $-53M | $-50M | $23M | $-64M | $-35M | $-34M | $4M | $-23M | $-30M | $-39M | $-42M | $-38M | |
| Interest Income | $5M | $5M | · | $2M | $2M | $3M | · | $2M | $2M | $3M | · | · | · | · | · | · | |
| Other Non-op | $-275.0K | $-80.0K | $234.0K | $324.0K | $-82.0K | $51.0K | $3M | $337.0K | $-18.0K | $365.0K | $171.0K | $118.0K | $1M | $-701.0K | $744.0K | $254.0K | |
| Pretax Income | $-69M | $-26M | $-53M | $-54M | $-50M | $-47M | $29M | $-62M | $-33M | $-32M | $7M | $-21M | $-27M | $-39M | $-41M | $-38M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-677.0K | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-69M | $-26M | $-53M | $-54M | $-50M | $-47M | $29M | $-62M | $-33M | $-32M | $7M | $-21M | $-27M | $-39M | $-41M | $-38M | |
| EPS (Basic) | $-0.34 | $-0.13 | $-0.29 | $-0.32 | $-0.31 | $-0.29 | $0.26 | $-0.47 | $-0.25 | $-0.24 | $0.07 | $-0.20 | $-0.27 | $-0.42 | $-0.62 | $-0.62 | |
| EPS (Diluted) | $-0.34 | $-0.13 | $-0.29 | $-0.32 | $-0.31 | $-0.29 | $0.26 | $-0.47 | $-0.25 | $-0.24 | $0.07 | $-0.20 | $-0.27 | $-0.42 | $-0.62 | $-0.62 | |
| Shares (Basic) | 204,008,712 | 200,167,869 | -325,604,079 | 167,739,208 | 163,987,640 | 162,572,026 | -253,084,680 | 132,563,467 | 129,527,003 | 129,271,678 | 106,025,063 | 105,462,414 | 102,056,712 | 93,900,484 | 66,479,293 | 60,516,616 | |
| Shares (Diluted) | 204,008,712 | 200,167,869 | -325,604,079 | 167,739,208 | 163,987,640 | 162,572,026 | -253,084,680 | 132,563,467 | 129,527,003 | 129,271,678 | 106,975,231 | 105,462,414 | 102,056,712 | 93,900,484 | 66,479,293 | 60,516,616 | |
| EBITDA | $-74M | $-31M | · | $-56M | $-53M | $-50M | · | $-64M | $-35M | $-34M | $4M | $-23M | $-30M | $-39M | $-42M | $-38M |
Stato Patrimoniale 24
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $368M | $545M | $602M | $196M | $208M | $243M | $302M | $311M | $154M | $181M | $140M | $173M | $208M | $97M | $123M | $62M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | $25M | $25M | $50M | |
| Receivables | $888.0K | $0 | $1M | $10M | $2M | · | $1M | $0 | $1M | $0 | $7M | · | · | · | · | · | |
| Prepaid Expense | $12M | $13M | $8M | $7M | $7M | $8M | $10M | $11M | $12M | $11M | $8M | $9M | $9M | $7M | $5M | $7M | |
| Other Current Assets | $4M | $3M | $3M | $3M | $7M | $7M | $7M | $3M | $5M | $5M | $4M | $3M | $3M | $2M | $7M | $6M | |
| Current Assets | $508M | $561M | $615M | $215M | $224M | $258M | $320M | $325M | $172M | $197M | $159M | $185M | $220M | $131M | $160M | $124M | |
| PP&E (Net) | $7M | $7M | $7M | $8M | $9M | $10M | $10M | $11M | $12M | $12M | $14M | $15M | $16M | $19M | $20M | $21M | |
| PP&E (Gross) | · | · | $57M | · | · | · | $56M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $51M | $50M | $50M | $49M | $48M | $47M | $46M | $45M | $44M | $44M | $42M | $40M | $39M | · | · | · | |
| Other Non-current Assets | $667.0K | $386.0K | $16.0K | $22.0K | $728.0K | $448.0K | $55.0K | · | · | · | · | · | · | · | · | · | |
| Total Assets | $558M | $584M | $638M | $241M | $252M | $288M | $352M | $359M | $209M | $235M | $200M | $230M | $267M | $182M | $213M | $167M | |
| Accounts Payable | $20M | $19M | $16M | $14M | $15M | $14M | $16M | $13M | $18M | $12M | $13M | $12M | $12M | $16M | $11M | $10M | |
| Accrued Liabilities | $5M | $5M | $7M | $5M | $3M | $2M | $5M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | |
| Current Liabilities | $51M | $50M | $95M | $86M | $87M | $87M | $111M | $171M | $173M | $166M | $100M | $140M | $133M | $64M | $64M | $58M | |
| Capital Leases | $40M | $7M | $9M | $11M | $14M | $16M | $18M | $20M | $22M | $24M | $27M | $29M | $31M | $34M | $35M | $24M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $190.0K | $190.0K | · | · | $868.0K | |
| Total Liabilities | $105M | $72M | $112M | $109M | $105M | $109M | $135M | $209M | $204M | $202M | $233M | $274M | $294M | $178M | $174M | $160M | |
| Common Stock | $1.63B | $1.63B | $1.62B | $1.22B | $1.19B | $1.18B | $1.18B | $1.14B | $951M | $950M | $841M | $840M | $838M | $803M | $802M | $751M | |
| Paid-in Capital | $248M | $237M | $228M | $174M | $168M | $161M | $156M | $153M | $136M | $132M | $127M | $125M | $122M | $117M | $113M | $92M | |
| Retained Earnings | $-1.42B | $-1.35B | $-1.33B | $-1.27B | $-1.22B | $-1.17B | $-1.12B | $-1.15B | $-1.09B | $-1.06B | $-1.01B | $-1.02B | $-995M | $-924M | $-885M | $-843M | |
| AOCI | $-172.0K | $-254.0K | $-250.0K | $-190.0K | $-161.0K | $-204.0K | $-262.0K | $-159.0K | $-279.0K | $-198.0K | $-182.0K | $-150.0K | $-50.0K | $-123.0K | $-47.0K | $95.0K | |
| Stockholders' Equity | $454M | $512M | $518M | $125M | $139M | $172M | $210M | $142M | $-3M | $25M | $-40M | $-52M | $-35M | $-5M | $31M | $-53.0K | |
| Liabilities + Equity | $558M | $584M | $638M | $241M | $252M | $288M | $352M | $359M | $209M | $235M | $200M | $230M | $267M | $182M | $213M | $167M | |
| Shares Outstanding | 193,277,622 | 192,337,566 | 187,660,263 | 160,288,481 | 155,673,292 | 154,093,313 | 153,037,286 | 148,392,939 | 122,479,289 | 122,321,384 | 99,011,901 | 98,566,816 | 98,104,844 | 86,841,523 | 86,724,658 | 60,859,968 |
Flusso di cassa 8
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-54M | $-60M | $-34M | $-45M | $-46M | $-63M | $-44M | $-46M | $-27M | $-33M | $-34M | $-37M | $86M | $-26M | $-29M | $-40M | |
| CapEx | $884.0K | $438.0K | $-1.0K | $248.0K | $306.0K | $165.0K | $86.0K | $383.0K | $52.0K | $417.0K | $198.0K | $72.0K | $489.0K | $457.0K | $492.0K | $208.0K | |
| Investing Cash Flow | $-123M | $-438.0K | $1.0K | $-248.0K | $-306.0K | $-165.0K | $-86.0K | $-383.0K | $-52.0K | $-417.0K | $-198.0K | $-72.0K | $-489.0K | $-501.0K | $25M | $-50M | |
| Stock Issued | · | · | · | · | · | · | · | $174M | $0 | $14M | $-35M | $-35M | $0 | $-229.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $14M | · | · | $35M | · | · | · | |
| Financing Cash Flow | $330.0K | $3M | $440M | $33M | $12M | $4M | $35M | $204M | $653.0K | $15M | $2M | $2M | $35M | $17.0K | $66M | $1M | |
| Net Change in Cash | $-177M | $-57M | $406M | $-12M | $-35M | $-59M | $-9M | $157M | $-27M | $-19M | $-33M | $-36M | $120M | $-26M | $61M | $-89M | |
| Free Cash Flow | · | $-60M | · | · | · | $-63M | · | · | · | $-34M | · | · | $85M | · | · | $-40M |
Redditività 7
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3248.3% | -81.8% | · | · | -606.5% | -542.8% | · | · | -177.7% | -274.8% | 9.0% | -106.2% | -234.2% | -13648.8% | -11243.7% | -2176.8% | |
| Net Margin | -3052.6% | -68.2% | · | · | -580.2% | -510.9% | · | · | -167.2% | -251.7% | 14.7% | -95.5% | -212.0% | -13685.6% | -11012.3% | -2160.8% | |
| Pretax Margin | -3052.6% | -68.2% | · | · | -580.2% | -510.9% | · | · | -167.2% | -251.7% | 13.4% | -95.5% | -212.0% | -13685.6% | -11012.3% | -2160.8% | |
| EBITDA Margin | -3248.3% | -81.8% | · | · | -606.5% | -542.8% | · | · | -177.7% | -274.8% | 9.0% | -106.2% | -234.2% | -13648.8% | -11243.7% | -2176.8% | |
| ROA | -17.1% | -6.0% | · | -17.9% | -21.9% | -17.9% | · | -22.1% | -15.0% | -12.6% | 3.8% | -9.5% | -12.6% | -20.4% | -19.7% | -18.4% | |
| ROE | -23.4% | -7.6% | · | -40.5% | -74.3% | -47.5% | · | -122.2% | 119.3% | 676.9% | -32.2% | 203.2% | 157.7% | -307.3% | -156.5% | -143.3% | |
| ROIC | -16.3% | -6.1% | · | -45.2% | -37.9% | -29.0% | · | -45.1% | 1006.5% | -135.7% | -12.1% | 45.4% | 87.2% | 860.8% | -136.2% | 71875.5% |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 11.3 | · | 2.5 | 2.6 | 3.0 | · | 1.9 | 1.0 | 1.2 | 1.6 | 1.3 | 1.7 | 2.0 | 2.5 | 2.1 | |
| Quick Ratio | 7.3 | 10.9 | · | 2.4 | 2.4 | 2.8 | · | 1.8 | 0.9 | 1.1 | 1.5 | 1.2 | 1.6 | 1.9 | 2.3 | 1.9 |
Efficienza 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | · | · | 0.0 | 0.0 | · | · | 0.1 | 0.0 | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 1.8 | · | · | · | 6.0 | · | · | · | 30.5 | 0.8 | 3.3 | · | · | · | · | · |
Valutazione (TTM) 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | $104M | $104M | $97M | $85M | $36M | $15M | $39M | $41M | · | |
| Net Income TTM | $-200M | $-177M | · | $-213M | $-192M | $-173M | · | $-119M | $-78M | $-73M | $-80M | $-129M | $-146M | $-124M | $-124M | $-125M | |
| Market Cap | $1.12B | $1.39B | · | $1.17B | $1.01B | $1.25B | · | $1.22B | $611M | $755M | $569M | $359M | $425M | $313M | $282M | $122M | |
| P/E | -5.3 | -6.9 | · | -5.3 | -4.9 | -6.5 | · | -9.2 | -8.0 | -9.6 | -7.0 | -2.4 | -2.2 | -2.0 | -1.5 | · | |
| P/S | · | · | · | · | · | · | · | 11.8 | 5.9 | 7.8 | 6.7 | 10.1 | 27.7 | 8.1 | 6.8 | · | |
| P/B | 2.5 | 2.7 | · | 9.4 | 7.3 | 7.2 | · | 8.6 | -175.8 | 29.7 | -14.1 | -6.9 | -12.2 | -69.4 | 9.1 | -2296.6 | |
| P / Tangible Book | 2.5 | 2.7 | · | 9.4 | 7.3 | 7.2 | · | 8.6 | · | 29.7 | · | · | · | · | 9.1 | · | |
| P / Cash Flow | · | -23.4 | · | · | · | -19.8 | · | · | · | -22.6 | · | · | 5.0 | · | · | -3.1 | |
| P / FCF | · | -23.2 | · | · | · | -19.7 | · | · | · | -22.3 | · | · | 5.0 | · | · | -3.0 | |
| Earnings Yield | -18.9% | -14.5% | · | -19.0% | -20.3% | -15.5% | · | -10.8% | -12.4% | -10.4% | -14.3% | -41.5% | -44.6% | -49.3% | -65.8% | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $43M | $108M | $113M | $4M | $41M |
| Utile netto | $-204M | $-97M | $-58M | $-162M | $-122M |
| EPS Diluito | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 264 filer · $892.5M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 56 (+5 vs trimestre precedente) | 37 (+1 vs trimestre precedente) | 93 (-18 vs trimestre precedente) | 59 (+4 vs trimestre precedente) | +16.8M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $156.727.684 | 26.975.505 | 17,56% | Azioni |
| GSK plc | $106.007.465 | 18.245.691 | 11,88% | Azioni |
| MAVERICK CAPITAL LTD | $59.715.848 | 10.278.115 | 6,69% | Azioni |
| Driehaus Capital Management LLC | $31.624.661 | 5.443.143 | 3,54% | Azioni |
| PRIMECAP MANAGEMENT CO/CA/ | $31.110.354 | 5.354.622 | 3,49% | Azioni |
| 683 Capital Management, LLC | $28.759.500 | 4.950.000 | 3,22% | Azioni |
| STATE STREET CORP | $28.116.432 | 4.839.317 | 3,15% | Azioni |
| READYSTATE ASSET MANAGEMENT LP | $27.464.678 | 4.727.139 | 3,08% | Azioni |
| M28 Capital Management LP | $26.657.930 | 4.588.284 | 2,99% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $21.541.656 | 3.707.686 | 2,41% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $19.277.729 | 3.317.246 | 2,16% | Azioni |
| FMR LLC | $17.099.004 | 2.943.030 | 1,92% | Azioni |
| ALGERT GLOBAL LLC | $16.370.343 | 2.817.615 | 1,83% | Azioni |
| Qube Research & Technologies Ltd | $16.128.560 | 2.776.000 | 1,81% | Azioni |
| Squarepoint Ops LLC | $14.765.778 | 2.541.442 | 1,65% | Azioni |
| VANGUARD GROUP INC | $14.386.233 | 846.249 | 1,61% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.263.463 | 2.110.751 | 1,37% | Azioni |
| MORGAN STANLEY | $12.000.799 | 2.065.542 | 1,34% | Azioni |
| Pfizer Inc | $10.931.250 | 1.875.000 | 1,22% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $10.523.548 | 1.811.282 | 1,18% | Azioni |
| D. E. Shaw & Co., Inc. | $10.296.645 | 1.772.228 | 1,15% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $10.175.651 | 1.751.403 | 1,14% | Azioni |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $9.920.932 | 1.746.643 | 1,11% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $9.903.261 | 1.704.520 | 1,11% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $9.201.210 | 1.583.685 | 1,03% | Azioni |
| GOLDMAN SACHS GROUP INC | $8.877.262 | 1.527.928 | 0,99% | Azioni |
| Point72 Asset Management, L.P. | $8.627.786 | 1.484.989 | 0,97% | Azioni |
| RTW INVESTMENTS, LP | $7.843.500 | 1.350.000 | 0,88% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7.114.025 | 1.224.445 | 0,80% | Azioni |
| EMERALD ADVISERS, LLC | $7.111.237 | 1.223.965 | 0,80% | Azioni |
| BlackRock, Inc. | $5.539.777 | 953.490 | 0,62% | Azioni |
| SymBiosis Capital Partners, LLC | $5.437.500 | 750.000 | 0,61% | Azioni |
| Pictet Asset Management Holding SA | $5.330.146 | 917.409 | 0,60% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $5.157.403 | 887.677 | 0,58% | Azioni |
| Aberdeen Group plc | $5.092.221 | 876.458 | 0,57% | Azioni |
| EMERALD MUTUAL FUND ADVISERS TRUST | $4.926.874 | 847.999 | 0,55% | Azioni |
| BAKER BROS. ADVISORS LP | $4.779.527 | 822.638 | 0,54% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $4.712.241 | 811.057 | 0,53% | Azioni |
| CAPITAL FUND MANAGEMENT S.A. | $4.268.874 | 734.746 | 0,48% | Azioni |
| SPHERA FUNDS MANAGEMENT LTD. | $3.708.360 | 638.272 | 0,42% | Azioni |
| Y-Intercept (Hong Kong) Ltd | $3.544.646 | 610.094 | 0,40% | Azioni |
| Susquehanna Portfolio Strategies, LLC | $3.533.607 | 608.194 | 0,40% | Azioni |
| TANG CAPITAL MANAGEMENT LLC | $3.486.000 | 600.000 | 0,39% | Azioni |
| Walleye Capital LLC | $3.401.482 | 585.453 | 0,38% | Azioni |
| CITADEL ADVISORS LLC | $2.789.695 | 480.154 | 0,31% | Azioni |
| BANK OF AMERICA CORP /DE/ | $2.569.042 | 442.176 | 0,29% | Azioni |
| XTX Topco Ltd | $2.556.011 | 439.933 | 0,29% | Azioni |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2.375.674 | 408.894 | 0,27% | Azioni |
| Connor, Clark & Lunn Investment Management Ltd. | $2.319.398 | 399.208 | 0,26% | Azioni |
| Trexquant Investment LP | $2.208.782 | 380.169 | 0,25% | Azioni |
| HSBC HOLDINGS PLC | $2.172.683 | 370.449 | 0,24% | Azioni |
| Woodline Partners LP | $2.036.585 | 350.531 | 0,23% | Azioni |
| Ishara Investments LP | $1.905.680 | 328.000 | 0,21% | Azioni |
| BARCLAYS PLC | $1.766.839 | 304.103 | 0,20% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.739.514 | 299.400 | 0,19% | Azioni |
| PLATINUM INVESTMENT MANAGEMENT LTD | $1.599.313 | 275.269 | 0,18% | Azioni |
| JPMORGAN CHASE & CO | $1.543.989 | 265.614 | 0,17% | Azioni |
| Swiss National Bank | $1.514.086 | 260.600 | 0,17% | Azioni |
| ExodusPoint Capital Management, LP | $1.458.728 | 251.072 | 0,16% | Azioni |
| Privium Fund Management B.V. | $1.400.268 | 241.010 | 0,16% | Azioni |
| F/m Investments LLC | $1.365.844 | 235.085 | 0,15% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.339.112 | 230.484 | 0,15% | Azioni |
| Newtyn Management, LLC | $1.249.150 | 215.000 | 0,14% | Azioni |
| TD Asset Management Inc | $1.127.291 | 194.026 | 0,13% | Azioni |
| ALPS ADVISORS INC | $1.125.780 | 193.766 | 0,13% | Azioni |
| RHUMBLINE ADVISERS | $1.125.195 | 193.667 | 0,13% | Azioni |
| Sofinnova Investments, Inc. | $1.099.560 | 189.253 | 0,12% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.052.744 | 145.206 | 0,12% | Azioni |
| Elmind Capital, LP | $1.033.285 | 177.846 | 0,12% | Azioni |
| ADAR1 Capital Management, LLC | $929.600 | 160.000 | 0,10% | Azioni |
| Bank of New York Mellon Corp | $911.560 | 156.895 | 0,10% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $904.293 | 124.730 | 0,10% | Azioni |
| Burkehill Global Management, LP | $871.500 | 150.000 | 0,10% | Azioni |
| BOOTHBAY FUND MANAGEMENT, LLC | $842.450 | 145.000 | 0,09% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $836.692 | 144.009 | 0,09% | Azioni |
| STATE OF WISCONSIN INVESTMENT BOARD | $830.981 | 143.026 | 0,09% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $801.995 | 138.037 | 0,09% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $775.635 | 133.500 | 0,09% | Opzione Call |
| CITIGROUP INC | $680.287 | 117.089 | 0,08% | Azioni |
| WELLS FARGO & COMPANY/MN | $675.395 | 116.247 | 0,08% | Azioni |
| James J. Burns & Company, LLC | $666.988 | 114.800 | 0,07% | Azioni |
| IEQ CAPITAL, LLC | $618.451 | 106.446 | 0,07% | Azioni |
| Cetera Investment Advisers | $609.341 | 104.878 | 0,07% | Azioni |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $608.336 | 104.705 | 0,07% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $604.211 | 103.995 | 0,07% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $593.782 | 102.200 | 0,07% | Opzione Put |
| Mariner, LLC | $593.759 | 102.195 | 0,07% | Azioni |
| Bridgefront Capital, LLC | $589.448 | 101.454 | 0,07% | Azioni |
| UBS Group AG | $531.034 | 91.400 | 0,06% | Opzione Call |
| MetLife Investment Management, LLC | $513.587 | 88.397 | 0,06% | Azioni |
| Ikarian Capital, LLC | $495.507 | 85.285 | 0,06% | Azioni |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $476.000 | 81.955 | 0,05% | Azioni |
| Entropy Technologies, LP | $467.409 | 80.449 | 0,05% | Azioni |
| EXCHANGE TRADED CONCEPTS, LLC | $467.310 | 80.432 | 0,05% | Azioni |
| Quadrature Capital Ltd | $459.368 | 79.065 | 0,05% | Azioni |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | $451.007 | 77.626 | 0,05% | Azioni |
| a16z Perennial Management, L.P. | $450.966 | 77.619 | 0,05% | Azioni |
| MARSHALL WACE, LLP | $443.645 | 76.359 | 0,05% | Azioni |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $432.450 | 74.432 | 0,05% | Azioni |
| FEDERATED HERMES, INC. | $408.304 | 70.276 | 0,05% | Azioni |
Insider aziendali 21 insider · 8 dirigenti · 9 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Paul Bolno | President and CEO | 05 Febbraio 2026 A | 275.520 | 0 | 2 | $-2.336.201 |
| Kyle Moran | Chief Financial Officer | 05 Febbraio 2026 A | 134.385 | 0 | 7 | $-4.151.988 |
| David G Gaiero | Interim CFO | 03 Marzo 2020 A | 6.392 | 0 | 0 | $0 |
| Keith Regnante | Chief Financial Officer | 07 Marzo 2019 A | 29.186 | 0 | 0 | $0 |
| Chris Francis | SVP, Corporate Development, Head of Emerging Areas | 26 Febbraio 2026 M | 61.867 | 0 | 14 | $-7.103.233 |
| Chandra Vargeese | Chief Technology Officer, Head of Platform Discovery Sciences | 05 Febbraio 2026 A | 408.246 | 0 | 1 | $-43.417 |
| Michael A. Panzara | Chief Medical Officer, Head of Therapeutics Discovery and Development | 25 Luglio 2022 A | 109.103 | 0 | 0 | $0 |
| Mark Baldry | Chief Commerical Officer | 05 Agosto 2019 A | 39.000 | 0 | 0 | $0 |
| Gregory L. Verdine | Direttore | 08 Dicembre 2025 S | 275.217 | 0 | 3 | $-369.461 |
| Christian O Henry | Direttore | 08 Dicembre 2025 M | 12.700 | 0 | 4 | $-1.369.324 |
| Mark Corrigan | Direttore | 08 Dicembre 2025 S | 28.815 | 0 | 2 | $-217.265 |
| Amy Pott | Direttore | 18 Agosto 2020 A | — | 0 | 0 | $0 |
| Peter Kolchinsky | Direttore | 18 Agosto 2020 A | — | 0 | 0 | $0 |
| Koji Miura | Direttore | 15 Agosto 2019 A | — | 0 | 0 | $0 |
| Masaharu Tanaka | Direttore | 10 Novembre 2016 A | — | 0 | 0 | $0 |
| Takeshi Wada | Direttore | 10 Novembre 2016 A | — | 0 | 0 | $0 |
| Adrian Rawcliffe | — | 12 Agosto 2026 S | 0 | 0 | 3 | $-806.604 |
| Tan Aik Na | — | 11 Agosto 2026 S | 24.968 | 0 | 10 | $-2.020.004 |
| Ken Takanashi | — | 11 Agosto 2026 S | 20.079 | 0 | 1 | $-23.223 |
| Heidi L Wagner | — | 11 Agosto 2026 M | 44.930 | 0 | 3 | $-231.070 |
| Roberto Guerciolini | — | 07 Dicembre 2016 M | 4.000 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 4 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×9 depositi | 11 Agosto 2026 | 16,80% | Modifica | — | SEC |
| Shin Nippon Biomedical Laboratories, Ltd., SNBL USA, Ltd., Ken Takanashi ×6 depositi | 12 Agosto 2022 | — | Deposito iniziale | — | SEC |
| Kagoshima Shinsangyo Sousei Investment Limited Partnership, Kagoshima Development Co. Ltd. ×5 depositi | 20 Luglio 2022 | — | Deposito iniziale | — | SEC |
| RA Capital Management, LLC, Peter Kolchinsky ×3 depositi | 28 Gennaio 2019 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 28 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| GNOM · Global X Funds | 1,03% | 87.259 NS | 31 Maggio 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 0,67% | 12.254 NS | 30 Aprile 2026 | N-PORT |
| IHE · iShares Trust | 0,20% | 541.635 SH | 08 Agosto 2026 | Giornaliero |
| IWC · iShares Trust | 0,19% | 463.783 SH | 08 Agosto 2026 | Giornaliero |
| IBB · iShares Trust | 0,07% | 1.158.886 SH | 08 Agosto 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 111.824 SH | 08 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | 0,05% | 1.196.960 SH | 08 Agosto 2026 | Giornaliero |
| RSSL · Global X Funds | 0,03% | 60.562 NS | 30 Aprile 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 3.525.539 SH | 08 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 793.588 SH | 08 Agosto 2026 | Giornaliero |
| ISCV · iShares Trust | 0,02% | 18.901 SH | 08 Agosto 2026 | Giornaliero |
| ISCB · iShares Trust | 0,01% | 6.085 SH | 08 Agosto 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,01% | 250.409 NS | 30 Aprile 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.751.403 SH | 08 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,01% | 390.910 SH | 08 Agosto 2026 | Giornaliero |
| ISCG · iShares Trust | 0,01% | 14.793 SH | 08 Agosto 2026 | Giornaliero |
| WSML · iShares Trust | 0,01% | 7.226 SH | 08 Agosto 2026 | Giornaliero |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 4.467 NS | 31 Maggio 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 86.005 SH | 08 Agosto 2026 | Giornaliero |
| DFAU · Dimensional ETF Trust | 0,00% | 43.085 NS | 30 Aprile 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1.463 NS | 30 Aprile 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 10.250 NS | 30 Aprile 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 63.707 SH | 08 Agosto 2026 | Giornaliero |
| ITOT · iShares Trust | 0,00% | 248.385 SH | 08 Agosto 2026 | Giornaliero |
| DFAC · Dimensional ETF Trust | 0,00% | 74.011 NS | 30 Aprile 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 18.648 NS | 30 Aprile 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 10.069 SH | 08 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 11.431 SH | 08 Agosto 2026 | Giornaliero |